Leukemia Research
Volume 29, Issue 2 , Pages 147-152 , February 2005

The peripheral blood Vα24+NKT cell numbers decrease in patients with haematopoietic malignancy

  • Ken-ichirou Yoneda

      Affiliations

    • The Second Department of Internal Medicine, Nara Medical University, 840 Shijo-cho, Kashihara City, Nara 634-8522, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 744 29 8854; fax: +81 744 29 0907.
    • ,
  • Takeshi Morii

      Affiliations

    • The Second Department of Internal Medicine, Nara Medical University, 840 Shijo-cho, Kashihara City, Nara 634-8522, Japan
    • ,
  • Mie Nieda

      Affiliations

    • Laboratory of Molecular Immunology, MEDINET Co., Ltd., 4-20-18 Seta Setagaya-ku, Tokyo 158-0095, Japan
    • ,
  • Nobuhiko Tsukaguchi

      Affiliations

    • The Second Department of Internal Medicine, Nara Medical University, 840 Shijo-cho, Kashihara City, Nara 634-8522, Japan
    • ,
  • Itsuto Amano

      Affiliations

    • The Second Department of Internal Medicine, Nara Medical University, 840 Shijo-cho, Kashihara City, Nara 634-8522, Japan
    • ,
  • Haruyuki Tanaka

      Affiliations

    • The Second Department of Internal Medicine, Nara Medical University, 840 Shijo-cho, Kashihara City, Nara 634-8522, Japan
    • ,
  • Hideo Yagi

      Affiliations

    • The Second Department of Internal Medicine, Nara Medical University, 840 Shijo-cho, Kashihara City, Nara 634-8522, Japan
    • ,
  • Nobuhiro Narita

      Affiliations

    • The Second Department of Internal Medicine, Nara Medical University, 840 Shijo-cho, Kashihara City, Nara 634-8522, Japan
    • ,
  • Hiroshi Kimura

      Affiliations

    • The Second Department of Internal Medicine, Nara Medical University, 840 Shijo-cho, Kashihara City, Nara 634-8522, Japan

Received 28 November 2003 ,Accepted 1 June 2004.

References 

  1. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, et al. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science. 1997;278:1626–1629
  2. Morita M, Motoki K, Akimoto K, Natori T, Sakai T, Sawa E, et al. Structure-activity relationship of α-galactosylceramides against B16-bearing mice. J Med Chem. 1995;38:2176–2187
  3. Nakagawa R, Motoki K, Ueno H, Iijima R, Nakamura H, Kobayashi E, et al. Treatment of hepatic metastasis of the clone 26 adenocarcinoma with an α-galactosylceramide, KRN7000. Cancer Res. 1998;58:1202–1207
  4. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Sato H, et al. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14NKT cells. Proc Natl Acad Sci U S A. 1998;95:5690–5693
  5. Toura I, Kawano T, Akutsu Y, Nakayama T, Ochiai T, Taniguchi M. Cutting edge; Inhibition of experimental tumor metastasis by dendritic cells pulsed with α-galactosylceramide. J Immunol. 1999;163:2387–2391
  6. Kawano T, Nakayama T, Kamada N, Kaneko Y, Harada M, Ogura N, et al. Antitumor cytotoxicity mediated by ligand-ativated human Vα24NKT cells. Cancer Res. 1999;59:5102–5105
  7. Muhammad Ali Tahir S, Cheng O, Shaulov A, Koezuka Y, Bubley G, Wilson S, et al. Loss of IFN-γ production by invariant NKT cells in advanced cancer. J Immunol. 2001;167:4046–4050
  8. Nishikawa K, Saito S, Morii T, Kato Y, Narita N, Ichijo M, et al. Differential expression of the interleukin 2 receptor β (p75) chain on human peripheral blood natural killer subsets. Int Immunol. 1990;2:481–486
  9. Kojo S, Adachi Y, Keino H, Taniguchi M, Sumida T. Dysfunction of T cell receptor AV24AJ18+BV11+double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum. 2001;44:1127–1138
  10. Takahashi T, Chiba S, Nieda M, Azuma T, Ishihara S, Shibata Y, et al. Cutting edge: analysis of human Vα24+CD8+NKTcells activated by α-galactosylceramide-pulsed monocyte-derived dendritic cells. J Immunol. 2002;168:3140–3144
  11. Nieda M, Nicol A, Koezuka Y, Kikuchi T, Takahashi H, Nakamura H, et al. Activation of human Vα24NKT cells by α-glycosylceramide in a CD1d-restricted and Vα24TCR-mediated manner. Hum Immunol. 1999;60:10–19
  12. Ishihara S, Nieda M, Kitayama J, Osada T, Yabe T, Kikuchi A, et al. α-Galactosylceramides enhance the antitumor cytotoxicity of hepatic lymphocytes obtained from cancer patients by activating CD3−CD56+NK cells in vitro. J Immunol. 2000;165:1659–1664
  13. Eberl G, MacDonald HR. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur J Immunol. 2000;30:985–992
  14. Sumida T, Sakamoto A, Murata H, Makino Y, Takahashi H, Yoshida S, et al. Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis. J Exp Med. 1995;182:1163–1168
  15. Sumida T, Maeda T, Taniguchi M, Nishioka K, Stohl W. TCR Vα24 gene expression in double negative T cells in systemic lupus erythematosus. Lupus. 1998;7:565–568
  16. Wilson SB, Kent SC, Patton KT, Orban T, Jackson RA, Exley M, et al. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature. 1998;391:177–181
  17. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: what’s in a name?. Nat Rev Immunol. 2004;4:231–237
  18. Fujii S, Shimizu K, Klimek V, Geller MD, Nimer SD, Dhodapkar MV. Severe and selective deficiency of interferon-γ-producing invariant natural killer T cells in patients with myelodysplastic syndromes. Brit J Haematol. 2003;122:617–622
  19. Gumperz JE, Miyake S, Yamamura T, Brenner MB. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med. 2002;195:625–636
  20. Lee PT, Benlagha K, Teyton L, Bendelac A. Distinct functional lineages of human Vα24 natural killer T cells. J Exp Med. 2002;195:637–641
  21. Yanagisawa K, Seino K, Ishikawa Y, Nozue M, Todoroki T, Fukao K. Impaired proliferative response of Vα24 NKT cells from cancer patients against α-galactosylceramide. J Immunol. 2002;168:6494–6499
  22. Dhodapkar MV, Geller MD, Chang DH, Shimizu K, Fujii S, Dhodapkar KM. A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma. J Exp Med. 2003;197:1667–1676

PII: S0145-2126(04)00229-2

doi: 10.1016/j.leukres.2004.06.005

Leukemia Research
Volume 29, Issue 2 , Pages 147-152 , February 2005

Article Tools

* Image Usage & Resolution